Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin.
Market Cap | 615.336 Million | Shares Outstanding | 47.37 Million | Avg 30-day Volume | 73.076 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.18 |
Price to Revenue | 27.3486 | Debt to Equity | 0.0 | EBITDA | -62.97 Million |
Price to Book Value | 1.7772 | Operating Margin | -574.702 | Enterprise Value | 117.526 Million |
Current Ratio | 10.612 | EPS Growth | 0.785 | Quick Ratio | 10.355 |
1 Yr BETA | 1.0568 | 52-week High/Low | 21.15 / 11.0 | Profit Margin | -569.5696 |
Operating Cash Flow Growth | -282.5019 | Altman Z-Score | 5.8951 | Free Cash Flow to Firm | -35.002 Million |
Earnings Report | 2023-03-16 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
DELANEY BRENDAN SEE REMARKS |
|
150,000 | 2023-01-03 | 3 |
DESAI NEIL EXECUTIVE CHAIRMAN |
|
150,000 | 2023-01-03 | 3 |
|
519,692 | 2022-09-26 | 2 | |
|
1,850,532 | 2022-09-26 | 2 | |
GIACOBELLO SCOTT M. CHIEF FINANCIAL OFFICER |
|
20,000 | 2022-09-26 | 2 |
|
3,471,752 | 2022-09-22 | 2 | |
|
18,573 | 2022-06-15 | 1 | |
|
18,573 | 2022-06-15 | 1 | |
|
18,573 | 2022-06-15 | 1 | |
ITRI LORETTTA M CHIEF MEDICAL OFFICER |
|
67,300 | 2022-04-01 | 1 |
THIBAULT LANCE E CHIEF FINANCIAL OFFICER |
|
0 | 2021-08-26 | 0 |
|
24,485 | 2021-06-30 | 0 | |
|
16,160 | 2021-06-30 | 0 | |
|
12,568 | 2021-06-30 | 0 | |
|
5,193,946 | 2020-12-08 | 0 | |
PETERS KEVIN G. SEE REMARKS |
|
0 | 2020-03-16 | 0 |
GARDNER JOSEPH H. PRESIDENT |
|
0 | 2020-03-16 | 0 |
MAREK REGINA VICE PRESIDENT OF FINANCE |
|
0 | 2020-03-16 | 0 |
|
0 | 2019-06-18 | 0 | |
|
0 | 2019-06-18 | 0 | |
HOFFMAN STEPHEN J CHIEF EXECUTIVE OFFICER |
|
0 | 2019-05-14 | 0 |
ROGERS MICHAEL W SEE REMARKS |
|
0 | 2019-05-14 | 0 |
|
No longer subject to file | 2019-04-25 | 0 | |
PAKOLA STEVE CHIEF MEDICAL OFFICER |
|
0 | 2019-02-15 | 0 |
DESAI DHAVAL CHIEF STRATEGY OFFICER |
|
75,342 | 2018-05-09 | 0 |
|
3,653,451 | 2017-03-15 | 0 | |
|
1,303,865 | 2017-03-15 | 0 | |
MURPHY JAMES B SEE REMARKS |
|
0 | 2017-03-15 | 0 |
PAPPAJOHN JOHN PRESIDENT |
|
2,000,000 | 2008-04-01 | 0 |
KINLEY MATTHEW P SECRETARY, CFO |
|
2,000,000 | 2008-04-01 | 0 |
|
1,000,000 | 2008-04-01 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DESAI NEIL - Director - Officer - > 10% Owner EXECUTIVE CHAIRMAN |
2023-01-04 16:05:55 -0500 | 2023-01-03 | A | 150,000 | a | 150,000 | direct | |||||||||
2023-01-04 16:08:45 -0500 | 2023-01-03 | A | 150,000 | a | 150,000 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
AADI BIOSCIENCE INC AADI | 2023-01-26 22:15:03 UTC | 2.3673 | 1.9527 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 21:45:03 UTC | 2.3673 | 1.9527 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 21:15:04 UTC | 2.3673 | 1.9527 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 20:45:03 UTC | 2.3476 | 1.9724 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 20:15:04 UTC | 2.3476 | 1.9724 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 19:45:03 UTC | 2.3476 | 1.9724 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 19:15:04 UTC | 2.3476 | 1.9724 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 18:45:03 UTC | 2.3476 | 1.9724 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 18:15:04 UTC | 2.3476 | 1.9724 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 17:45:04 UTC | 2.3476 | 1.9724 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 17:15:04 UTC | 2.3476 | 1.9724 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 16:45:03 UTC | 2.4758 | 1.8442 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 16:15:04 UTC | 2.4758 | 1.8442 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 15:45:03 UTC | 2.4758 | 1.8442 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 15:15:04 UTC | 2.4758 | 1.8442 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 14:45:04 UTC | 2.7536 | 1.5664 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 14:15:03 UTC | 2.7536 | 1.5664 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 13:45:03 UTC | 2.7536 | 1.5664 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 13:15:04 UTC | 2.7536 | 1.5664 | 100000 |
AADI BIOSCIENCE INC AADI | 2023-01-26 12:45:04 UTC | 2.7536 | 1.5664 | 100000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | AADI | -600.0 shares, $-8478.0 | 2022-09-30 | N-PORT |